KY
Kyowa Kirin Co., Ltd.
KYKOF · OTC
$14.50 -8.23% (-$1.30)
1M -8.23%
Market Cap ¥1.29T
P/E Ratio 15.88x
Div. Yield 2.66%
ROE 9.14%
Bulios Fair Price
$21.38
47.4% upside
Current Price
$14.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KYKOF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
88 /100
Cheap P/E 15.88x
EV/EBITDA 6.63x
P/S 2.44x
Growth
67 /100
Growing EPS growth 8.75%
Rev. growth 7.67%
FCF growth 43.37%
Profitability
95 /100
Strong Gross margin 74.12%
Net margin 15.35%
Op. margin 22.56%
Quality
51 /100
Average ROIC 10.05%
ROE 9.14%
ROA 7.24%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 2.84x
Int. coverage 39.67x
Stability
75 /100
Stable Beta 0.42x
Rev. volatility 6.48%
EPS volatility 38.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KYKOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Abdul Hafeez Mullick
Employees
5,161
Headquarters
Tokyo
Upcoming events
29 OCT
Earnings
Upcoming earnings report
31 DEC
Ex-Dividend
Ex-dividend date